Croda International has acquired Solus Biotech. The South-Korean company develops and produces biotechnology-derived active ingredients for beauty care and pharmaceuticals. The portfolio comprises biotech-derived ceramide and phospholipid technologies as well as natural retinol. According to Croda, this acquisition will increase its exposure to targeted prestige segments. The location in South Korea is said to create a new biotechnology R&D hub in the region. Further information …